If you or any of your family members over the age of 7 are referred by a GP for suspected Autism, Attention Deficit Hyperactivity Disorder (ADHD), Dyslexia, Dysgraphia or Dyscalculia, you have access to assessment, diagnosis and initial support through the specialist service provided by our selected provider. The referral can be from any GP. But, as ADHD is usually managed by ongoing medication and some online GPs are not able to support this, you may wish to speak to your practice GP if ADHD is suspected.

As soon as you have a GP referral you can call your Personal Advisory team. We’ll discuss the service with you and send a link to register with our selected provider’s online portal so you can book an initial needs assessment.

Assessments are available from 8 am to 7pm, Monday to Friday (subject to appointment availability and excluding Bank Holidays).

Assessment and support – The service gives you access to the following:

• An initial needs assessment to determine the required assessment(s).
• Online assessment(s), a feedback discussion and a downloadable report on the assessment findings.
• Group sessions following diagnosis of ADHD and/or Autism to better understand your condition(s).
• Sessions with an educational expert (Education Navigator). They will provide information on the support available in your local area and how best to access it. This does not include supporting Educational Health Care Plan (EHCP) applications, further reports or attendance at meetings.
• A medication service when medication is recommended following a diagnosis of ADHD by the AXA selected provider. The aim of the service is to find the best dose for you. There is no benefit for the cost of out-patient drugs so you will have to self-pay for a private prescription which could be a significant monthly amount. After an initial period to monitor your response to the medication, your care will need to be transferred to your GP. The AXA selected provider will support with this process. Alternatively, you can pay for ongoing reviews yourself. The AXA selected provider will be able to explain this if the option of medication is discussed with you.

This Neurodiversity Assessment and Support Service is not available to children under 7 years old. Members will need online access and an email address to use this service. AXAs selected provider will be responsible for your assessment, diagnosis and any support given. They will decide which post diagnosis support services are suitable for you and the number of sessions.

Learning and developmental disorders

The plan pays for the assessment, diagnosis and initial support for Autism, Attention Deficit Hyperactivity Disorder (ADHD), Dyslexia, Dysgraphia and Dyscalculia when:

• your GP refers you; and
• the member receiving support is aged 7 or over; and
• the AXA provider has carried out an initial needs assessment and agreed the service is suitable for you; and
• you use the online Neurodiversity Assessment and Support Service provided by our selected provider for assessment, diagnosis and support.

Your referral can be from any GP. However, some online GPs are not able to support ongoing prescriptions, so you may wish to speak to your practice GP.

What’s included

The service gives you access to the following:

• An initial needs assessment to determine the required assessments.
• Online assessment(s), a feedback discussion and a downloadable report on the assessment findings.
• Group sessions following diagnosis of ADHD and/or Autism to better understand your condition(s).
• Sessions with an educational expert (Education Navigator). They will provide information on the support available in your local area and how best to access it. This does not include supporting Educational Health Care Plan (EHCP) applications, further reports or attendance at meetings.
• A medication service when medication is recommended following a diagnosis of ADHD by our selected provider. The aim of the service is to find the best dose for you. There is no benefit for the cost of out-patient drugs so you will have to self-pay for a private prescription which could be a significant monthly amount.

After initial support is provided by the medication service, your care will be transferred to your GP for ongoing medical management and prescriptions. The AXA selected provider will liaise with them during the transfer. Alternatively, you can pay for ongoing reviews yourself. The AXA selected provider will be able to explain this if the option of medication is discussed with you.

The AXA selected provider will decide which of the post-diagnosis support services are suitable for you and the number of sessions you need.

What’s not included

The service can only be used for the listed neurodiverse conditions.

If you do not use the Neurodiversity Assessment and Support Service with our selected provider, there is no benefit for neurodiverse conditions under the healthcare scheme.

The service is not suitable for everyone. The AXA selected provider will discuss your clinical circumstances and advise if the service is appropriate for you.

There is no access to the assessment and support services listed unless the AXA selected provider has agreed they are suitable for you.

The educational expert will give you information on support in your local area. However, you’ll need to liaise with local services yourself. There is no benefit for supporting Educational Health Care Plan (EHCP) applications, further reports or attendance at meetings.

There is no benefit for out-patient drugs, even if your prescription is being monitored by the medicine review team. You will need to self-fund the cost of a private prescription, which could be a significant monthly amount.

The medicine review is only available following an ADHD diagnosis by our selected provider and not for any other condition.

Except as part of the assessment, diagnosis and initial support of the conditions detailed, the plan does not pay for anything to do with:

• speech delay
• learning disorders
• educational problems
• behavioural problems
• physical development
• psychological development

For more information, click here.